IP Library Granted Patent US 9,022,945
Granted Patent B2
US 9,022,945 · App. 14/172,776 · Granted May 5, 2015

Methods and systems that monitor for an impending myocardial infarction

Inventors: Timothy A. Fayram (Gilroy, CA); Daniell Dokko (Mountain View, CA); Taraneh Ghaffari Farazi (San Jose, CA); Mark Carlson (Calabasas, CA)
Assignee: Pacesetter, Inc.
A61B5/686A61B5/0084A61B5/02125A61B5/026A61B5/0295A61B5/0535A61B5/0538A61B5/1459A61N1/36521A61N1/36557A61B5/7242A61B5/02007A61B5/0205A61B5/02154A61B5/02416A61B5/04012A61B5/0402A61B5/4836A61B5/746
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,022,945
App. No.
14/172,776
Granted
May 5, 2015
Kind
B2
Abstract

Implantable systems, and methods for use therewith, are provided for monitoring for an impending myocardial infarction. A signal indicative of changes in arterial blood volume is obtained. Such a signal can be a photoplethysmography signal or an impedance plethysmography signal. For each of a plurality of periods of time, a metric indicative of the areas under the curve of the signal or number of inflections in the signal is determined. An impending myocardial infarction is monitored for based on changes in the metric indicative of the area under the curve of the signal or number of inflections in the signal, and an alert and/or therapy is triggered in response to an impending myocardial infarction being predicted.

Claims (37)

1. For use with a chronically implanted device, a method for monitoring for an impending myocardial infarction (MI), comprising:

(a) obtaining

a first signal indicative of changes arterial volume, the first signal comprising one of a photoplethysmography (PPG) signal or an impedance-plethysmography (IPG) signal, and

a second signal indicative of electrical cardiac activity, the second signal comprising one of an electrocardiogram (ECG) signal or an intracardiac electrogram (IEGM) signal;

(b) determining, based on the first and second signals, a metric indicative of aortic pulse wave velocity (PWV);

(c) determining, based on the first signal, a metric indicative of diastolic blood pressure (DBP);

(d) determining, based on at least one of the first and or second signals, a metric indicative of heart rate (HR);

(e) determining, based on the first signal, a metric indicative of vascular stiffness (VS) by determining a measure of a number of inflections in the first signal, wherein a greater the measure of the number of inflections in the first signal a greater the vascular stiffness;

(f) monitoring for an impending MI based on the metrics indicative of PWV, DBP, HR and VS, wherein an increase in each of the metrics indicative of PWV, DBP, HR and VS is interpreted as an increase in a risk of an impending MI; and

(g) triggering an alert and/or therapy in response to an impending MI being detected at step (f);

wherein one or more of steps (b) through (g) is/are performed using a processor.

2. The method of claim 1 , wherein step (f) comprises detecting an impending MI if the metrics indicative of PWV, DBP, HR and VS each satisfies a corresponding criteria indicative of an impending MI.

3. The method of claim 1 , wherein step (f) comprises detecting an impending MI if a majority of the metrics indicative of PWV, DBP, HR and VS each satisfies a corresponding criteria indicative of an impending MI.

4. The method of claim 1 , wherein:

the first signal indicative of changes arterial volume, that is obtained at step (a), is a photoplethysmography (PPG) signal; and

step (e) comprises determining, based on the PPG signal, a metric indicative of vascular stiffness (VS) by determining a measure of a number of inflections in the PPG signal, wherein a greater the measure of the number of inflections in the PPG signal a greater the vascular stiffness.

5. The method of claim 1 , wherein:

the first signal indicative of changes arterial volume, that is obtained at step (a), is an impedance-plethysmography (IPG) signal; and

step (e) comprises determining, based on the IPG signal, a metric indicative of vascular stiffness (VS) by determining a measure of a number of inflections in the IPG signal, wherein a greater the measure of the number of inflections in the IPG signal a greater the vascular stiffness.

6. A system for monitoring for an impending myocardial infarction (MI), comprising:

a sensor configured to produce a first signal that is indicative of changes in arterial volume;

one or more electrodes to produce a second signal indicative of electrical cardiac activity, the second signal comprising one of an electrocardiogram (ECG) signal or an intracardiac electrogram (IEGM) signal; and

a monitor configured to

determine, based on the first and second signals, a metric indicative of aortic pulse wave velocity (PWV);

determine, based on the first signal, a metric indicative of diastolic blood pressure (DBP);

determine, based on at least one of the first and second signals, a metric indicative of heart rate (HR);

determine, based on the first signal, a metric indicative of vascular stiffness (VS) by determining a measure of a number of inflections in the first signal, wherein a greater the measure of the number of inflections in the first signal a greater the vascular stiffness;

monitor for an impending MI based on the metrics indicative of PWV, DBP, HR and VS, wherein an increase in each of the metrics indicative of PWV, DBP, HR and VS is interpreted as an increase in a risk of an impending MI; and

trigger an alert and/or therapy in response to an impending MI being detected.

7. The system of claim 6 , wherein the monitor is configured to detect an impending MI if the metrics indicative of PWV, DBP, HR and VS each satisfies a corresponding criteria indicative of an impending MI.

8. The system of claim 6 , wherein the monitor is configured to detect an impending MI if a majority of the metrics indicative of PWV, DBP, HR and VS each satisfies a corresponding criteria indicative of an impending MI.

9. The system of claim 6 , wherein:

the first signal indicative of changes arterial volume, that is obtained by the sensor, is a photoplethysmography (PPG) signal; and

the monitor is configured to determine, based on the PPG signal, a metric indicative of vascular stiffness (VS) by determining a measure of a number of inflections in the PPG signal, wherein a greater the measure of the number of inflections in the PPG signal a greater the vascular stiffness.

10. The system of claim 6 , wherein:

the first signal indicative of changes arterial volume, that is obtained by the sensor, is an impedance-plethysmography (IPG) signal; and

the monitor is configured to determine, based on the IPG signal, a metric indicative of vascular stiffness (VS) by determining a measure of a number of inflections in the IPG signal, wherein a greater the measure of the number of inflections in the IPG signal a greater the vascular stiffness.

Continuity (2)
Division 12499738 · Jul 8, 2009
Related Publication 20140155707A1 · Jun 5, 2014